Envoke Secures £1 Million to Enhance Healthcare Training
In the rapidly evolving landscape of healthcare technology, innovation is paramount. The latest spotlight shines on Envoke, a UK-based company revolutionizing how medical staff are trained to use laboratory equipment. With recent funding of £1 million from NPIF – Mercia Equity Finance and Finance Yorkshire’s Seedcorn Fund, Envoke is poised to reshape training in the medical sector. This funding comes as the company has demonstrated its capacity for growth, attracting leading manufacturers and enhancing its platform's capabilities.
Founded in 2019 by Stuart Warrington, Envoke emerged from a background in film and animation production.
. Originally intended for product demonstrations, it became clear that a greater need existed for a system focused on remote training and troubleshooting. Envoke's simulation software creates a virtual model for each machine, pioneering e-learning for medical devices. This innovative approach allows manufacturers to provide remote support, significantly cutting down on the need for physical site visits. With clients that include Bio-Rad, Waters Corporation, and the NHS, the platform is now utilized in labs worldwide, further underscoring the potential impact of this technology on staffing efficiency in healthcare.
The recent investment of £1 million will enable Envoke to enhance its system, boost marketing efforts, and expand its customer base in anticipation of a future Series A investment. As CEO Stuart Warrington notes, the platform holds the potential to significantly increase productivity, reducing warranty costs and minimizing machine downtime due to user error. With plans to create additional jobs and a track record of nearly doubling annual recurring revenue in just a year, Envoke exemplifies how focused investment and innovative solutions can transform the healthcare training landscape. With further support from entities like Finance Yorkshire and the Northern Powerhouse Investment Fund, this dynamic company is set to lead the charge in healthcare technology advancement.
Key Terms Explained
- Innovation
- In the context of startups and investing, this refers to creating, developing, and implementing new methods, ideas, or products with the aim of growing a company or bringing something new to the market.
- Series A investment
- This refers to the first significant round of venture capital financing for a startup. It follows initial seed or startup capital, and it is intended to further develop, scale, or market a proven business model/product.
- Annual Recurring Revenue (ARR)
- This financial metric is used by companies with subscription-based business models to measure the predictable and recurring revenue components of their businesses. It's a measure of the underlying health and potential profitability of these companies.
Frequently Asked Questions
- What is the primary focus of UK-based company Envoke?-Envoke is primarily focused on revolutionizing how medical staff are trained to use laboratory equipment. They are doing this through their innovative simulation software that creates virtual models of each machine.
- Who provided the recent funding of £1 million for Envoke?+
- What is the significance of the £1 million investment for Envoke?+
- Who are some of the notable clients of Envoke?+
- What impact does the Envoke platform have on productivity according to CEO Stuart Warrington?+
They've invested in Envoke
Get to know these SaaS investors
Click here for a full list of 6,908+ startup investors in the UK